Harmony Biosciences Holdings Inc (HRMY)
34.06
-0.89
(-2.55%)
USD |
NASDAQ |
Dec 24, 16:00
Harmony Biosciences Holdings Profit Margin (Quarterly): 24.78% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Regeneron Pharmaceuticals Inc | 36.03% |
| Dyne Therapeutics Inc | -- |
| Arrowhead Pharmaceuticals Inc | -- |
| Incyte Corp | 9.36% |
| EyePoint Pharmaceuticals Inc | -279.0% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 23.59% |
| Return on Assets | 14.52% |
| Return on Invested Capital | 17.28% |
| Gross Profit Margin (Quarterly) | 77.01% |
| Operating Margin (Quarterly) | 33.17% |
| Return on Net Operating Assets | 53.56% |